BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30238808)

  • 1. Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome.
    Jurj A; Pop L; Petrushev B; Pasca S; Dima D; Frinc I; Deak D; Desmirean M; Trifa A; Fetica B; Gafencu G; Selicean S; Moisoiu V; Micu WT; Berce C; Sacu A; Moldovan A; Colita A; Bumbea H; Tanase A; Dascalescu A; Zdrenghea M; Stiufiuc R; Leopold N; Tetean R; Burzo E; Tomuleasa C; Berindan-Neagoe I
    Crit Rev Clin Lab Sci; 2018 Nov; 55(7):501-515. PubMed ID: 30238808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of microRNA in the pathogenesis of Richter syndrome.
    Van Roosbroeck K; Bayraktar R; Calin S; Bloehdorn J; Dragomir MP; Okubo K; Bertilaccio MTS; Zupo S; You MJ; Gaidano G; Rossi D; Chen SS; Chiorazzi N; Thompson PA; Ferrajoli A; Bertoni F; Stilgenbauer S; Keating MJ; Calin GA
    Haematologica; 2019 May; 104(5):1004-1015. PubMed ID: 30409799
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Balatti V; Tomasello L; Rassenti LZ; Veneziano D; Nigita G; Wang HY; Thorson JA; Kipps TJ; Pekarsky Y; Croce CM
    Blood; 2018 Nov; 132(20):2179-2182. PubMed ID: 30242085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic Leukemia.
    Stamatopoulos B; Van Damme M; Crompot E; Dessars B; Housni HE; Mineur P; Meuleman N; Bron D; Lagneaux L
    Mol Med; 2015 Jan; 21(1):123-33. PubMed ID: 25584781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of microRNA-223 in lymphocytic leukemia cells and its action mechanism].
    Nan Z; Liang Y; Fu R; Liu H; Ruan EB; Wang XM; Wang GJ; Qu W; Liu H; Wu YH; Song J; Xing LM; Guan J; Li LJ; Wang HQ; Shao ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):556-61. PubMed ID: 23815897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome.
    Rossi D; Spina V; Cerri M; Rasi S; Deambrogi C; De Paoli L; Laurenti L; Maffei R; Forconi F; Bertoni F; Zucca E; Agostinelli C; Cabras A; Lucioni M; Martini M; Magni M; Deaglio S; Ladetto M; Nomdedeu JF; Besson C; Ramponi A; Canzonieri V; Paulli M; Marasca R; Larocca LM; Carbone A; Pileri SA; Gattei V; Gaidano G
    Clin Cancer Res; 2009 Jul; 15(13):4415-22. PubMed ID: 19509140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Richter transformation with c-MYC overexpression: report of three cases.
    Wang L; Aghel A; Peterson B; Wang-Rodriguez J; Wang HY; Zhao XF
    Int J Clin Exp Pathol; 2015; 8(6):7540-6. PubMed ID: 26261666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
    Jamroziak K; Tadmor T; Robak T; Polliack A
    Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling.
    Yeh YY; Ozer HG; Lehman AM; Maddocks K; Yu L; Johnson AJ; Byrd JC
    Blood; 2015 May; 125(21):3297-305. PubMed ID: 25833959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Richter syndrome: pathogenesis and management.
    Rossi D; Gaidano G
    Semin Oncol; 2016 Apr; 43(2):311-9. PubMed ID: 27040710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.
    Chigrinova E; Rinaldi A; Kwee I; Rossi D; Rancoita PM; Strefford JC; Oscier D; Stamatopoulos K; Papadaki T; Berger F; Young KH; Murray F; Rosenquist R; Greiner TC; Chan WC; Orlandi EM; Lucioni M; Marasca R; Inghirami G; Ladetto M; Forconi F; Cogliatti S; Votavova H; Swerdlow SH; Stilgenbauer S; Piris MA; Matolcsy A; Spagnolo D; Nikitin E; Zamò A; Gattei V; Bhagat G; Ott G; Zucca E; Gaidano G; Bertoni F
    Blood; 2013 Oct; 122(15):2673-82. PubMed ID: 24004666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL.
    Rodríguez-Vicente AE; Quwaider D; Benito R; Misiewicz-Krzeminska I; Hernández-Sánchez M; de Coca AG; Fisac R; Alonso JM; Zato C; de Paz JF; García JL; Sarasquete ME; Hernández JÁ; Corchado JM; González M; Gutiérrez NC; Hernández-Rivas JM
    BMC Cancer; 2015 Apr; 15():238. PubMed ID: 25880332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group.
    Tadmor T; Shvidel L; Goldschmidt N; Ruchlemer R; Fineman R; Bairey O; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A
    Anticancer Res; 2014 Feb; 34(2):785-90. PubMed ID: 24511013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation.
    Playa-Albinyana H; Arenas F; Royo R; Giró A; López-Oreja I; Aymerich M; López-Guerra M; Frigola G; Beà S; Delgado J; Garcia-Roves PM; Campo E; Nadeu F; Colomer D
    Leukemia; 2024 Mar; 38(3):557-569. PubMed ID: 38017105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
    Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
    Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway.
    Lenartova A; Randen U; Johannesen TB; Tjønnfjord GE
    Cancer Epidemiol; 2019 Jun; 60():128-133. PubMed ID: 30986631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome.
    Fabbri G; Khiabanian H; Holmes AB; Wang J; Messina M; Mullighan CG; Pasqualucci L; Rabadan R; Dalla-Favera R
    J Exp Med; 2013 Oct; 210(11):2273-88. PubMed ID: 24127483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.
    Dal Bo M; D'Agaro T; Gobessi S; Zucchetto A; Dereani S; Rossi D; Zaja F; Pozzato G; Di Raimondo F; Gaidano G; Laurenti L; Del Poeta G; Efremov DG; Gattei V; Bomben R
    Oncotarget; 2015 Aug; 6(22):19102-17. PubMed ID: 26036258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis.
    Rossi D; Spina V; Forconi F; Capello D; Fangazio M; Rasi S; Martini M; Gattei V; Ramponi A; Larocca LM; Bertoni F; Gaidano G
    Int J Cancer; 2012 Jun; 130(12):3006-10. PubMed ID: 21796624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLL Exosomes Modulate the Transcriptome and Behaviour of Recipient Stromal Cells and Are Selectively Enriched in miR-202-3p.
    Farahani M; Rubbi C; Liu L; Slupsky JR; Kalakonda N
    PLoS One; 2015; 10(10):e0141429. PubMed ID: 26509439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.